Shaken, not Stirred: Amgen Abandons Weight Loss Pill but Moves Forward with Injectable Drug

Amgen's Weight Loss Rollercoaster

Ah the ups and downs of the weight loss drug space much like my Aston Martin rides through the streets of Rome. Amgen ditches the oral weight loss pill in favor of the injectable MariTide treatment. Smart move Amgen. It's all about adaptability just like adapting to new villains in each movie.

Injectable Innovation by Amgen

Amgen is going full Bond mode with their injectable obesity treatment MariTide. They're aiming to shoot down the competition like I take down bad guys – with style and precision. The injectable treatment helps patients lose weight differently. Sounds like a gadget Q would have come up with.

Riding the Stock Market Waves

Amgen's shares on the rise like my heart rate during a high speed chase. Investors are keeping an eye on Amgen's weight loss pipeline. It's like waiting for the big reveal in a mystery movie will Amgen emerge as the hero?

Quarterly Results: Making a Comeback

Amgen's first quarter results are top notch just like the gadgets in my spy kit. Revenue and earnings beat expectations partly thanks to Horizon Therapeutics products. Looks like Amgen is gearing up for an action packed sequel.